Skip to main content
. 2019 Jun 11;19:564. doi: 10.1186/s12885-019-5629-x

Fig. 1.

Fig. 1

Flow diagram shows the inclusion and exclusion of eligible patients. BOT borderline malignant ovarian tumor, CA-125 cancer antigen 125, EOC epithelial ovarian cancer, US ultrasound